Webster Bank’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$103K Buy
+541
New +$102K 0.01% 294
2026
Q1
Sell
-531
Closed -$97.6K 683
2025
Q4
$97.6K Hold
531
0.01% 280
2025
Q3
$81.5K Hold
531
0.01% 305
2025
Q2
$74.2K Sell
531
-82
-13% -$11.5K 0.01% 315
2025
Q1
$90K Hold
613
0.01% 289
2024
Q4
$80.3K Hold
613
0.01% 305
2024
Q3
$95.4K Hold
613
0.01% 290
2024
Q2
$95.5K Hold
613
0.01% 279
2024
Q1
$83K Sell
613
-45
-7% -$5.96K 0.01% 286
2023
Q4
$88.6K Hold
658
0.01% 280
2023
Q3
$89.1K Buy
658
+531
+418% +$72.5K 0.01% 257
2023
Q2
$18.2K Hold
127
﹤0.01% 409
2023
Q1
$17.6K Hold
127
﹤0.01% 428
2022
Q4
$17K Hold
127
﹤0.01% 421
2022
Q3
$14K Hold
127
﹤0.01% 430
2022
Q2
$17K Hold
127
﹤0.01% 417
2022
Q1
$17K Hold
127
﹤0.01% 435
2021
Q4
$15K Hold
127
﹤0.01% 457
2021
Q3
$15K Buy
+127
New +$14.8K ﹤0.01% 445
2020
Q1
Sell
-100
Closed -$10K 505
2019
Q4
$10K Buy
+100
New +$9.41K ﹤0.01% 445

Other funds holding AZN

Webster Bank's AZN Position: Q2 2026 in Review

Webster Bank opened a new position in AstraZeneca (AZN) in Q2 2026: 541 shares worth $103K. The stake represents 0.01% of the portfolio and ranks #294 among its holdings. This is a return to the name: Webster Bank previously reported a position in AZN as recently as Q4 2025.

Webster Bank first reported a position in AZN in Q4 2019 and has held it in 20 quarters since. 1,495 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Webster Bank held 541 shares of AstraZeneca worth $103K as of Q2 2026.
  • AstraZeneca was a new Webster Bank position in Q2 2026.
  • AstraZeneca made up 0.01% of Webster Bank's portfolio in Q2 2026, its #294 holding.
  • Webster Bank first reported a position in AstraZeneca in Q4 2019 and has held it in 20 quarters since.
  • 1,495 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Webster Bank's 13F filing for Q2 2026, filed 20 Jul 2026.